Skip to content

Clinical trials

Phase 1/2 Pancreatic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1/2 Country / region: China Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20154
20164
20173
20185
20193
20204
20216
20224
20235
202410
20256
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting28
Unknown status13
Completed11
Not yet recruiting6
Active, not recruiting3
Withdrawn3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fuda Cancer Hospital, Guangzhou6
Chinese PLA General Hospital4
Beijing Biotech3
Chongqing Precision Biotech Co., Ltd3
West China Hospital3
Changhai Hospital2
Essen Biotech2
Fudan University2
Jiangsu HengRui Medicine Co., Ltd.2
PersonGen BioTherapeutics (Suzhou) Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms66
Stomach Neoplasms14
Colorectal Neoplasms13
Breast Neoplasms10
Ovarian Neoplasms10
Lung Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Esophageal Neoplasms7
Carcinoma, Hepatocellular6
Colonic Neoplasms5

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.